Cytogenetics of Shwachman Diamond syndrome: 27 years report of the Italian cohort and review of the literature.
Twenty-seven years of blood monitoring in a rare bone marrow disorder reveals when cancer develops, informing surveillance schedules and risk assessment.
The Italian RI-SDS working group reports 27 years of cytogenetic surveillance in Shwachman-Diamond syndrome patients from the national registry, providing the largest single-country dataset characterizing clonal evolution patterns, MDS/AML transformation risk, and cytogenetic-clinical correlations. This landmark dataset informs evidence-based surveillance intervals and risk stratification for this rare bone marrow failure syndrome with significant AML risk.
What the study was
- Study design
- 27-year longitudinal cohort study (Italian RI-SDS working group registry)
- Population
- Patients with Shwachman-Diamond syndrome in the Italian national registry (RI-SDS)
- Category
- Genomics/Precision Medicine
- Maturity
- Validated
- Journal
- European journal of medical genetics
Why it surfaced
Rare bone marrow failure syndrome with significant AML risk. 27-year Italian registry provides longest follow-up cytogenetic data on SDS. Relevant to both rare disease surveillance (T9) and hematologic malignancy risk (T1). Valli R, Pasquali F from Università degli Studi di Pavia.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.